AAAAAA

   
Results: 1-23 |
Results: 23
Human immunodeficiency virus (HIV)-specific immune responses are generatedwith the simultaneous vaccination of a gp120-depleted, whole-killed HIV-1 immunogen with cytosine-phosphorothioate-guanine dinucleotide immunostimulatory sequences of DNA
Authors: Moss, RB Diveley, J Jensen, FC Gouveia, E Carlo, DJ
Citation: Rb. Moss et al., Human immunodeficiency virus (HIV)-specific immune responses are generatedwith the simultaneous vaccination of a gp120-depleted, whole-killed HIV-1 immunogen with cytosine-phosphorothioate-guanine dinucleotide immunostimulatory sequences of DNA, J HUMAN VIR, 4(1), 2001, pp. 39-43
A double-blind, adjuvant-controlled trial of human immunodeficiency virus type 1 (HIV-1) immunogen (Remune) monotherapy in asymptomatic, HIV-1-infected Thai subjects with CD4-cell counts of > 300 (vol 7, pg 728, 2000)
Authors: Churdboonchart, V Sakondhavat, C Kulpradist, S Ayudthya, BIN Chandeying, V Rugpao, S Boonshuyar, C Sukeepaisarncharoen, W Sirawaraporn, W Carlo, DJ Moss, R
Citation: V. Churdboonchart et al., A double-blind, adjuvant-controlled trial of human immunodeficiency virus type 1 (HIV-1) immunogen (Remune) monotherapy in asymptomatic, HIV-1-infected Thai subjects with CD4-cell counts of > 300 (vol 7, pg 728, 2000), CL DIAG LAB, 8(6), 2001, pp. 1295-1295
Vaccination with a CDR2 BV6S2/6S5 peptide in adjuvant induces peptide-specific T-cell responses in patients with multiple sclerosis
Authors: Morgan, EE Nardo, CJ Diveley, JP Kunin, J Bartholomew, RM Moss, RB Carlo, DJ
Citation: Ee. Morgan et al., Vaccination with a CDR2 BV6S2/6S5 peptide in adjuvant induces peptide-specific T-cell responses in patients with multiple sclerosis, J NEUROSC R, 64(3), 2001, pp. 298-301
Expression of perforin on HIV-1-specific CD8(+) lymphocytes after immunization with a gp120-depleted, whole-killed HIV-1 immunogen
Authors: Moss, RB Giermakowska, WK Wallace, MR Jensen, FC Maigetter, RZ Carlo, DJ
Citation: Rb. Moss et al., Expression of perforin on HIV-1-specific CD8(+) lymphocytes after immunization with a gp120-depleted, whole-killed HIV-1 immunogen, CLIN EXP IM, 124(2), 2001, pp. 248-254
HIV-1-specific CD4 helper function in persons with chronic HIV-1 infectionon antiviral drug therapy as measured by ELISPOT after treatment with an inactivated, gp120-depleted HIV-1 in incomplete Freund's adjuvant
Authors: Moss, RB Webb, E Giermakowska, WK Jensen, FC Savary, JR Wallace, MR Carlo, DJ
Citation: Rb. Moss et al., HIV-1-specific CD4 helper function in persons with chronic HIV-1 infectionon antiviral drug therapy as measured by ELISPOT after treatment with an inactivated, gp120-depleted HIV-1 in incomplete Freund's adjuvant, J ACQ IMM D, 24(3), 2000, pp. 264-269
Insights into HIV-specific immune function: Implications for therapy and prevention in the new millennium
Authors: Moss, RB Jensen, FC Carlo, DJ
Citation: Rb. Moss et al., Insights into HIV-specific immune function: Implications for therapy and prevention in the new millennium, CLIN IMMUNO, 95(2), 2000, pp. 79-84
CXCR4 and CCR5 expression on CD4(+) T cells in vivo and HIV-1 antigen beta-chemokine production in vitro after treatment with HIV-1 immunogen (REMUNE)
Authors: Moss, RB Giermakowska, WK Diveley, JP Savary, JR Wallace, MR Maigetter, RZ Jensen, FC Carlo, DJ
Citation: Rb. Moss et al., CXCR4 and CCR5 expression on CD4(+) T cells in vivo and HIV-1 antigen beta-chemokine production in vitro after treatment with HIV-1 immunogen (REMUNE), J HUMAN VIR, 3(1), 2000, pp. 44-49
HIV-specific CD4(+) and CD8(+) immune responses are generated with a gp120-depleted, whole-killed HIV-1 immunogen with CpG immunostimulatory sequences of DNA
Authors: Moss, RB Diveley, J Jensen, FC Gouveia, E Savary, J Carlo, DJ
Citation: Rb. Moss et al., HIV-specific CD4(+) and CD8(+) immune responses are generated with a gp120-depleted, whole-killed HIV-1 immunogen with CpG immunostimulatory sequences of DNA, J INTERF CY, 20(12), 2000, pp. 1131-1137
T-helper-cell proliferative responses to whole-killed human immunodeficiency virus type 1 (HIV-1) and p24 antigens of different clades in HIV-1-infected subjects vaccinated with HIV-1 immunogen (Remune)
Authors: Moss, RB Giermakowska, W Wallace, MR Savary, J Jensen, F Carlo, DJ
Citation: Rb. Moss et al., T-helper-cell proliferative responses to whole-killed human immunodeficiency virus type 1 (HIV-1) and p24 antigens of different clades in HIV-1-infected subjects vaccinated with HIV-1 immunogen (Remune), CL DIAG LAB, 7(5), 2000, pp. 724-727
A double-blind, adjuvant-controlled trial of human immunodeficiency virus type 1 (HIV-1) immunogen (Remune) monotherapy in asymptomatic, HIV-1-infected Thai subjects with CD4-Cell counts of > 300
Authors: Churdboonchart, V Sakondhavat, C Kulpradist, S Isarangkura, B Ayudthya, BIN Chandeying, V Rugpao, S Boonshuyar, C Sukeepaisarncharoen, W Sirawaraporn, W Carlo, DJ Moss, R
Citation: V. Churdboonchart et al., A double-blind, adjuvant-controlled trial of human immunodeficiency virus type 1 (HIV-1) immunogen (Remune) monotherapy in asymptomatic, HIV-1-infected Thai subjects with CD4-Cell counts of > 300, CL DIAG LAB, 7(5), 2000, pp. 728-733
Enhancement of HIV type 1 antigen-specific CD4(+) T cell memory in subjects with chronic HIV type 1 infection receiving an HIV type 1 immunogen
Authors: Maino, VC Suni, MA Wormsley, SB Carlo, DJ Wallace, MR Moss, RB
Citation: Vc. Maino et al., Enhancement of HIV type 1 antigen-specific CD4(+) T cell memory in subjects with chronic HIV type 1 infection receiving an HIV type 1 immunogen, AIDS RES H, 16(6), 2000, pp. 539-547
Enhancement of HIV type 1 antigen-specific CD4(+) T cell memory in subjects with chronic HIV type 1 infection receiving an HIV type 1 immunogen (vol 16, pg 539, 2000)
Authors: Maino, VC Suni, MA Wormsley, SB Carlo, DJ Wallace, MR Moss, RB
Citation: Vc. Maino et al., Enhancement of HIV type 1 antigen-specific CD4(+) T cell memory in subjects with chronic HIV type 1 infection receiving an HIV type 1 immunogen (vol 16, pg 539, 2000), AIDS RES H, 16(18), 2000, pp. 2065-2066
Gene expression monitoring for gene discovery in models of peripheral and central nervous system differentiation, regeneration, and trauma
Authors: Farlow, DN Vansant, G Cameron, AA Chang, J Khoh-Reiter, S Pham, NL Wu, W Sagara, Y Nicholls, JG Carlo, DJ Ill, CR
Citation: Dn. Farlow et al., Gene expression monitoring for gene discovery in models of peripheral and central nervous system differentiation, regeneration, and trauma, J CELL BIOC, 80(2), 2000, pp. 171-180
Strength of conjugate binding to plasmid DNA affects degradation rate and expression level in vivo
Authors: Mullen, PM Lollo, CP Phan, QC Amini, A Banaszczyk, MG Fabrycki, JM Wu, DP Carlo, AT Pezzoli, P Coffin, CC Carlo, DJ
Citation: Pm. Mullen et al., Strength of conjugate binding to plasmid DNA affects degradation rate and expression level in vivo, BBA-GEN SUB, 1523(1), 2000, pp. 103-110
Cell-mediated immune responses to autologous virus in HIV-1-seropositive individuals after treatment with an HIV-1 immunogen
Authors: Moss, RB Giermakowska, WK Wallace, MR Savary, JR Jensen, FC Carlo, DJ
Citation: Rb. Moss et al., Cell-mediated immune responses to autologous virus in HIV-1-seropositive individuals after treatment with an HIV-1 immunogen, AIDS, 14(16), 2000, pp. 2475-2478
In vitro immune function after vaccination with an inactivated, gp120-depleted HIV-1 antigen with immunostimulatory oligodeoxynucleotides
Authors: Moss, RB Diveley, J Jensen, F Carlo, DJ
Citation: Rb. Moss et al., In vitro immune function after vaccination with an inactivated, gp120-depleted HIV-1 antigen with immunostimulatory oligodeoxynucleotides, VACCINE, 18(11-12), 2000, pp. 1081-1087
Interleukin 2 gene therapy of colorectal carcinoma with autologous irradiated tumor cells and genetically engineered fibroblasts: A phase I study
Authors: Sobol, RE Shawler, DL Carson, C Van Beveren, C Mercola, D Fakhrai, H Garrett, MA Barone, R Goldfarb, P Bartholomew, RM Brostoff, S Carlo, DJ Royston, I Gold, DP
Citation: Re. Sobol et al., Interleukin 2 gene therapy of colorectal carcinoma with autologous irradiated tumor cells and genetically engineered fibroblasts: A phase I study, CLIN CANC R, 5(9), 1999, pp. 2359-2365
Poly-L-lysine-graft-PEG-comb-type polycation copolymers for gene delivery
Authors: Banaszczyk, MG Lollo, CP Kwoh, DY Phillips, AT Amini, A Wu, DP Mullen, PM Coffin, CC Brostoff, SW Carlo, DJ
Citation: Mg. Banaszczyk et al., Poly-L-lysine-graft-PEG-comb-type polycation copolymers for gene delivery, J MACR S PU, A36(7-8), 1999, pp. 1061-1084
Cell-associated HIV-1 messenger RNA and DNA in T-helper cell and monocytesin asymptomatic HIV-1-infected subjects on HAART plus an inactivated HIV-1immunogen
Authors: Patterson, BK Carlo, DJ Kaplan, MH Marecki, M Pawha, S Moss, RB
Citation: Bk. Patterson et al., Cell-associated HIV-1 messenger RNA and DNA in T-helper cell and monocytesin asymptomatic HIV-1-infected subjects on HAART plus an inactivated HIV-1immunogen, AIDS, 13(13), 1999, pp. 1607-1611
Stabilization of poly-L-lysine/DNA polyplexes for in vivo gene delivery tothe liver
Authors: Kwoh, DY Coffin, CC Lollo, CP Jovenal, J Banaszczyk, MG Mullen, P Phillips, A Amini, A Fabrycki, J Bartholomew, RM Brostoff, SW Carlo, DJ
Citation: Dy. Kwoh et al., Stabilization of poly-L-lysine/DNA polyplexes for in vivo gene delivery tothe liver, BBA-GENE ST, 1444(2), 1999, pp. 171-190
Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status
Authors: Garzino-Demo, A Moss, RB Margolick, JB Cleghorn, F Sill, A Blattner, WA Cocchi, F Carlo, DJ DeVico, AL Gallo, RC
Citation: A. Garzino-demo et al., Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status, P NAS US, 96(21), 1999, pp. 11986-11991
Phenotypic analysis of human immunodeficiency virus (HIV) type 1 cell-mediated immune responses after treatment with an HIV-1 immunogen
Authors: Moss, RB Wallace, MR Giermakowska, WK Webb, E Savary, J Chamberlin-Brandt, C Theofan, G Musil, R Richieri, SP Jensen, FC Carlo, DJ
Citation: Rb. Moss et al., Phenotypic analysis of human immunodeficiency virus (HIV) type 1 cell-mediated immune responses after treatment with an HIV-1 immunogen, J INFEC DIS, 180(3), 1999, pp. 641-648
Tumor cell surface expression of granulocyte-macrophage colony-stimulatingfactor elicits antitumor immunity and protects from tumor challenge in theP815 mouse mastocytoma tumor model
Authors: Hoo, WS Lundeen, KA Kohrumel, JR Pham, NL Brostoff, SW Bartholomew, RW Carlo, DJ
Citation: Ws. Hoo et al., Tumor cell surface expression of granulocyte-macrophage colony-stimulatingfactor elicits antitumor immunity and protects from tumor challenge in theP815 mouse mastocytoma tumor model, J IMMUNOL, 162(12), 1999, pp. 7343-7349
Risultati: 1-23 |